Immunotherapy for early triple negative breast cancer: research agenda for the next decade von Tarantino, Paolo, Corti, Chiara, Schmid, Peter, Cortes, Javier, Mittendorf, Elizabeth A., Rugo, Hope, Tolaney, Sara M., Bianchini, Giampaolo, Andrè, Fabrice, Curigliano, Giuseppe

Volltext

Developing Anticancer Drugs in Orphan Molecular Entities — A Paradigm under Construction von André, Fabrice

Volltext

Alpelisib for PIK3CA-Mutated, Hormone Receptor–Positive Advanced Breast Cancer von André, Fabrice, Ciruelos, Eva, Rubovszky, Gabor, Campone, Mario, Loibl, Sibylle, Rugo, Hope S, Iwata, Hiroji, Conte, Pierfranco, Mayer, Ingrid A, Kaufman, Bella, Yamashita, Toshinari, Lu, Yen-Shen, Inoue, Kenichi, Takahashi, Masato, Pápai, Zsuzsanna, Longin, Anne-Sophie, Mills, David, Wilke, Celine, Hirawat, Samit, Juric, Dejan

Volltext

PI3K inhibitors are finally coming of age von Vanhaesebroeck, Bart, Perry, Matthew W. D., Brown, Jennifer R., André, Fabrice, Okkenhaug, Klaus

Volltext

HER2-Low Breast Cancer: Pathological and Clinical Landscape von Tarantino, Paolo, Hamilton, Erika, Tolaney, Sara M, Cortes, Javier, Morganti, Stefania, Ferraro, Emanuela, Marra, Antonio, Viale, Giulia, Trapani, Dario, Cardoso, Fatima, Penault-Llorca, Frédérique, Viale, Giuseppe, Andrè, Fabrice, Curigliano, Giuseppe

Volltext

Palbociclib in Hormone-Receptor–Positive Advanced Breast Cancer von Turner, Nicholas C, Ro, Jungsil, André, Fabrice, Loi, Sherene, Verma, Sunil, Iwata, Hiroji, Harbeck, Nadia, Loibl, Sibylle, Huang Bartlett, Cynthia, Zhang, Ke, Giorgetti, Carla, Randolph, Sophia, Koehler, Maria, Cristofanilli, Massimo

Volltext

Natural and therapy-induced immunosurveillance in breast cancer von Kroemer, Guido, Senovilla, Laura, Galluzzi, Lorenzo, André, Fabrice, Zitvogel, Laurence

Volltext

New clinical trials in CUP and a novel paradigm in cancer classification von Rassy, Elie, André, Fabrice

Volltext

Targeting FGFR Signaling in Cancer von Touat, Mehdi, Ileana, Ecaterina, Postel-Vinay, Sophie, André, Fabrice, Soria, Jean-Charles

Volltext

The need for pragmatic, affordable, and practice-changing real-life clinical trials in oncology von Leary, Alexandra, Besse, Benjamin, André, Fabrice

Volltext

The Genetic Landscape and Clonal Evolution of Breast Cancer Resistance to Palbociclib plus Fulvestrant in the PALOMA-3 Trial von O'Leary, Ben, Cutts, Rosalind J, Liu, Yuan, Hrebien, Sarah, Huang, Xin, Fenwick, Kerry, André, Fabrice, Loibl, Sibylle, Loi, Sherene, Garcia-Murillas, Isaac, Cristofanilli, Massimo, Huang Bartlett, Cynthia, Turner, Nicholas C

Volltext

Cyclin E1 Expression and Palbociclib Efficacy in Previously Treated Hormone Receptor-Positive Metastatic Breast Cancer von Turner, Nicholas C, Liu, Yuan, Zhu, Zhou, Loi, Sherene, Colleoni, Marco, Loibl, Sibylle, DeMichele, Angela, Harbeck, Nadia, André, Fabrice, Bayar, Mohamed Amine, Michiels, Stefan, Zhang, Zhe, Giorgetti, Carla, Arnedos, Monica, Huang Bartlett, Cynthia, Cristofanilli, Massimo

Volltext

Dendritic cell-derived exosomes as immunotherapies in the fight against cancer von Pitt, Jonathan M, Charrier, Mélinda, Viaud, Sophie, André, Fabrice, Besse, Benjamin, Chaput, Nathalie, Zitvogel, Laurence

Volltext

Genomic characterization of metastatic breast cancers von Bertucci, François, Ng, Charlotte K. Y., Patsouris, Anne, Droin, Nathalie, Piscuoglio, Salvatore, Carbuccia, Nadine, Soria, Jean Charles, Dien, Alicia Tran, Adnani, Yahia, Kamal, Maud, Garnier, Séverine, Meurice, Guillaume, Jimenez, Marta, Dogan, Semih, Verret, Benjamin, Chaffanet, Max, Bachelot, Thomas, Campone, Mario, Lefeuvre, Claudia, Bonnefoi, Herve, Dalenc, Florence, Jacquet, Alexandra, De Filippo, Maria R., Babbar, Naveen, Birnbaum, Daniel, Filleron, Thomas, Le Tourneau, Christophe, André, Fabrice

Volltext

Overcoming Resistance to Tumor-Targeted and Immune-Targeted Therapies von Aldea, Mihaela, Andre, Fabrice, Marabelle, Aurelien, Dogan, Semih, Barlesi, Fabrice, Soria, Jean-Charles

Volltext

Rationale for targeting fibroblast growth factor receptor signaling in breast cancer von Cortes, Javier, Andre, Fabrice

Volltext

Forget lung, breast or prostate cancer: why tumour naming needs to change von André, Fabrice, Rassy, Elie, Marabelle, Aurélien, Michiels, Stefan, Besse, Benjamin

Volltext

Bodywide ecological interventions on cancer von Kroemer, Guido, McQuade, Jennifer L., Merad, Miriam, André, Fabrice, Zitvogel, Laurence

Volltext

Targeted therapies for ER+/HER2- metastatic breast cancer von Yamamoto-Ibusuki, Mutsuko, Arnedos, Monica, André, Fabrice

Volltext

Advances in the treatment of advanced oestrogen-receptor-positive breast cancer von Turner, Nicholas C, PhD, Neven, Patrick, Prof, Loibl, Sibylle, Prof, Andre, Fabrice, Prof

Volltext